Amreen Husain - Concepedia

Author

Amreen Husain

Also Known As

A Husain, A. Husain, A.A. Husain, Amreen Husain, Aprilia Husain, B. Stimec, C.D. Runowicz, H. Alony, Jeanette Baker, M. Coutts

114

Publications

11.4K

Citations

H-Index

Concepts

All Affiliations

Stanford University Memorial Sloan Kettering Cancer Center University of California, Irvine Medical Center University of California, San Francisco Stanford Medicine

About

Amreen Husain is an author at Stanford University specializing in medicine, oncology, and obstetrics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	25	36	3.6K
2	Health Sciences	4	4	304
3	Public Health	3	3	305
4	Engineering	1	1	90
5	Language Studies	1	1	14

Amreen Husain

Publications

11.3K

Citations

H-Index

Page 1

	Year	Citations
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer Peter Schmid, Sylvia Adams, Hope S. Rugo, New England Journal of Medicine	2018	4.2K
OCEANS: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Chemotherapy With or Without Bevacizumab in Patients With Platinum-Sensitive Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Carol Aghajanian, Stephanie V. Blank, Barbara A. Goff, Journal of Clinical Oncology	2012	1.4K
Atezolizumab plus nab-paclitaxel as first-line treatment for unresectable, locally advanced or metastatic triple-negative breast cancer (IMpassion130): updated efficacy results from a randomised, double-blind, placebo-controlled, phase 3 trial Peter Schmid, Hope S. Rugo, Sylvia Adams, The Lancet Oncology Breast OncologyOncologyMedicineBreast CancerPharmacotherapy	2019	1.2K
Therapeutic role of lymph node resection in endometrioid corpus cancer John K. Chan, Michael K. Cheung, Warner K. Huh, Cancer	2006	402
Final overall survival and safety analysis of OCEANS, a phase 3 trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent ovarian cancer Carol Aghajanian, Barbara A. Goff, Lawrence R. Nycum, Gynecologic Oncology MedicineCancer ManagementGynecologySafety AnalysisFinal Overall Survival	2015	306
BRCA1 up-regulation is associated with repair-mediated resistance to cis-diamminedichloroplatinum(II). Amreen Husain, Gang He, E. S. Venkatraman, PubMed Genome InstabilityBrca1 Up-regulationCell RegulationMolecular RegulationBrca1 Protein	1998	290
Atezolizumab and <i>nab</i>-Paclitaxel in Advanced Triple-Negative Breast Cancer: Biomarker Evaluation of the IMpassion130 Study Leisha A. Emens, Luciana Molinero, Sherene Loi, JNCI Journal of the National Cancer Institute	2021	284
Trends in demographic and clinical characteristics in women diagnosed with corpus cancer and their potential impact on the increasing number of deaths Stefanie Ueda, Daniel S. Kapp, Michael K. Cheung, American Journal of Obstetrics and Gynecology Corpus CancerPotential ImpactMedicineCancer ManagementCarcinoma	2008	216
Prognostic Factors for Uterine Cancer in Reproductive-Aged Women Nita K. Lee, Michael K. Cheung, Jacob Y. Shin, Obstetrics and Gynecology	2007	194
Prognostic factors responsible for survival in sex cord stromal tumors of the ovary—An analysis of 376 women Mallory Zhang, Michael K. Cheung, Jacob Y. Shin, Gynecologic Oncology Prognostic FactorsOvary—an AnalysisTumoral PathologyMedicineReproductive Health	2006	183

Page 1